Speeple News Search

Sign Up! | Tags | Domains | Statistics | Options | Advanced Search

Tags » Biotech

Related tags: biotech research, boston, boston blog main, drug manufacturers, drugs, equities, health care, life sciences, national blog main, seattle

  1. Health Winners & Losers: Wyeth

    thestreet.com » TheStreet.com - 5 hours ago

    Wyeth shares lose 6.5% and Medicis gains 12.45% on a day of little news and great volatility.

    Also tagged: drugs, dna, wye, teva, health care, gild, winners and losers, biib, mrx, equities

  2. Biotech Earnings Preview: A Place to Hide?

    thestreet.com » TheStreet.com - 6 hours ago

    Biotech stocks face challenges due to seasonality, raised expectations and the foreign exchange rate, but investors may turn to the sector in a defensive move.

    Also tagged: drugs, dna, jnj, amgn, earnings, business news, health care, celg, gild, biib, supg, equities

  3. Top biotech, biopharma employers

    fiercehealthcare.com » Untitled News Source - 7 hours ago

    Interested in stepping out of clinical practice and checking out a biotech or biopharma career? Here's a chance to do some research on where to look for options. Courtesy of Science magazine, our sister publication …

    Also tagged: monsanto, biopharma, science magazine, genetech

  4. Dendreon Raises $20M in Stock Sale to Azimuth

    xconomy.com » Xconomy Life Sciences Feed - 7 hours ago

    Biotech, Dendreon, Provenge Luke Timmerman wrote: Dendreon, the Seattle biotech company, said today in a regulatory filing that it raised $20 million by selling 3.6 million shares of common stock at $5.54 a share to …

    Also tagged: seattle, prostate cancer, life sciences, provenge, dendreon, azimuth, seattle briefs

  5. Onyx Attractive, but Issues Remain

    thestreet.com » TheStreet.com - 10 hours ago

    Onyx Pharmaceuticals stock deserves to be higher, but the company first needs to better lay out its plans for growth.

    Also tagged: drugs, dna, gsk, health care, onxx, bmy, equities

  6. UW, Microsoft Research Aim to Turn Northwest Into a Neural Engineering Hotspot

    UW, Microsoft Research Aim to Turn Northwest Into a Neural Engineering Hotspot

    xconomy.com » Xconomy Life Sciences Feed - 11 hours ago

    Biotech, Neuroscience, Yoky Matsuoka Luke Timmerman wrote: The minute I walked into an auditorium at Microsoft Research in Redmond last night, I knew this was going to be a fun event. In foot-high letters, someone …

    Also tagged: apple, microsoft research, seattle, neuroscience, university of washington, steve jobs, paul allen, national science foundation, life sciences, desney tan, national blog main, seattle blog main, yoky matsuoka, pacific northwest center for neural engineering, rajesh rao, tom daniel

  7. Biotech Mailbag: Onyx Attractive, But Issues Remain

    thestreet.com » RealMoney by TheStreet.com - 14 hours ago

    Onyx Pharmaceuticals stock deserves to be higher, but the company first needs to better lay out its plans for growth.

    Also tagged: dna, gsk, onxx, bmy, equities, fundamental analysis

  8. Cypress Bioscience, Developer of Fibromyalgia Drug, Eagerly Awaits FDA Deadline

    Cypress Bioscience, Developer of Fibromyalgia Drug, Eagerly Awaits FDA Deadline

    xconomy.com » Xconomy - 19 hours ago

    Biotech, Fibromyalgia, Cypress Bioscience Luke Timmerman wrote: Cypress Bioscience is one of those biotech companies that has limped along for more than 20 years, losing loads of money. In the lovely language of chief …

    Also tagged: fda, san diego, pfizer, amgen, eli lilly, cymbalta, lyrica, fibromyalgia, life sciences, humira, cypress bioscience, abbott laboratories, forest laboratories, enbrel, national blog main, san diego blog main, milnacipran, sabrina johnson
  9. Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career”

    Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career”

    xconomy.com » Xconomy Seattle - 19 hours ago

    Biotech, Leroy Hood, Institute for Systems Biology Luke Timmerman wrote: It’s hard to believe Leroy Hood—a guy busy enough to employ not one, but two full-time executive assistants—is turning 70 today. But it’s true …

    Also tagged: bill gates, seattle, hillary clinton, starbucks, applied biosystems, luxembourg, stanford, multiple sclerosis, bank of america, university of washington, h5n1, caltech, harvard, flu, national institutes of health, charles darwin, university of virginia, life sciences, lemelson mit prize, rheumatoid arthritis, kyoto prize, baylor medical center, human genome project, lake union, seattle art museum, national blog main, seattle blog main, leroy hood, oxford bioscience partners, george church, buerk dale victor, institute for systems biology, irving weissman, david galas, integrated diagnostics, swedish neuroscience institute, complete genomics, alan aderem, tim hunkapiller, lasker award amgen, valerie logan, artie buerk, rosetta inpharmatics, cathryn campbell, reudi aebersold, doug fambrough, shurgard storage, gary raisl, essential baking company, paul kearney
  10. Institute for Systems Biology, UW Researchers Win Bulk of $68M Grants To Study Flu, SARS

    Institute for Systems Biology, UW Researchers Win Bulk of $68M Grants To Study Flu, SARS

    xconomy.com » Xconomy Seattle - 20 hours ago

    Biotech, Flu, SARS Luke Timmerman wrote: Seattle researchers snapped up the lion’s share of a massive round of grants announced today by the National Institutes of Health. The Institute for Systems Biology, the …

    Also tagged: sars, seattle, university of washington, flu, tuberculosis, vanderbilt university, peter doherty, life sciences, pacific northwest national laboratory, anthony fauci, university of california san diego, national blog main, seattle blog main, institute for systems biology, alan aderem, michael katze, st jude children s hospital, joshua adkins

1  2  3  4  5  6  7  8  9  10  …